Covered recipient · General Payments record
VENUMADHAVI GOGINENI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$478.42
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $267.75 | 8 |
| Education | $173.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $134.35 | 2 |
| SOBI, INC | $89.99 | 1 |
| ABBVIE INC. | $83.99 | 1 |
| UCB, Inc. | $44.60 | 2 |
| Genmab U.S., Inc. | $28.16 | 1 |
| Janssen Pharmaceuticals, Inc | $26.31 | 1 |
| PFIZER INC. | $18.78 | 1 |
| La Jolla Pharmaceutical Company | $15.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $83.99 | 12/03/2024 | Education | Undisputed | 01/23/2026 | 1104195838 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.65 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101461715 | CMS |
| E.R. Squibb & Sons, L.L.C. | $119.70 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101461869 | CMS |
| Genmab U.S., Inc. | $28.16 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126833211 | CMS |
| Janssen Pharmaceuticals, Inc | $26.31 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078053928 | CMS |
| La Jolla Pharmaceutical Company | $15.55 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154248398 | CMS |
| PFIZER INC. | $18.78 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131492190 | CMS |
| SOBI, INC | $89.99 | 09/26/2024 | Education | Undisputed | 01/23/2026 | 1141414536 | CMS |
| UCB, Inc. | $24.25 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143388328 | CMS |
| UCB, Inc. | $20.35 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143388332 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.